임신 중 methyl bimatoprost acidate을 피해야 할까요? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

methyl bimatoprost acidate은 임신 중 안전한가요?

H361 (‘suspected of damaging fertility or the unborn child’) is reported for this substance in supplier/EU SDS/C&L‑type entries and the SCCS included methyl bimatoprost acidate among prostaglandin analogues of concern for cosmetic use; animal reproductive studies with bimatoprost show abortion, increased resorptions and post‑natal pup effects at high doses, and the Latisse/Lumigan product label advises caution in pregnancy. These facts support h=2 (suspected). Mechanistically, prostaglandin analogues have demonstrated reproductive/developmental effects in animal studies (m=2). Systemic absorption from topical/ocular application is low but measurable, so exposure from cosmetic topical use is low but real (e=1). Sources: SCCS opinion, FDA/LATISSE label, supplier SDS.

methyl bimatoprost acidate은 모유 수유 중 안전한가요?

Supplier safety data and regulatory/product labels record H362 (may cause harm to breast‑fed children) and state bimatoprost is excreted in milk in animal studies. Given the parent drug is excreted in milk (per product labels) and the substance is classed with H362 in SDSs, h=2 is appropriate. Mechanism evidence (excretion into milk, documented neonatal effects in animal studies) supports m=2. Exposure by topical cosmetic use is low but measurable (e=1). Sources: FDA/LATISSE label, supplier SDSs.

methyl bimatoprost acidate은 아기 피부에 안전한가요?

Do not increase hazard (h) or mechanism (m) absent infant‑specific data; retain h=2 and m=2 because the substance is a prostaglandin analogue with suspected reproductive/lactation hazards. Increase exposure (e) by +1 for baby skin per instructions because infant skin is more permeable and systemic exposure from topical application is measurable — therefore e=2 for 0–3‑year‑old skin. Sources: SCCS opinion, FDA product label, supplier SDSs.

VeriMom은 methyl bimatoprost acidate을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 methyl bimatoprost acidate을 20/100 (높은 위험)로 평가합니다.

임신 중 methyl bimatoprost acidate 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.